Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flutiform pMDI vs Seretide in Mild to Moderate-Severe Asthma
NCT00476073Phase 3Completed
- Sponsor
- Mundipharma
- Start
- Apr 2007
- Primary completion
- Jan 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of fluticasone propionate + formoterol in asthma (2 arms), sponsored by Mundipharma. Primary endpoint: Forced Expiratory Volume in 1 second. Started Apr 2007; status: completed.
02
Drugs
fluticasone propionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00476073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00476073.